Fundraising Fox
Roca Therapeutics
Nice, FR · 3 known investors
Find your way into Roca Therapeutics
Sign up to see every warm intro you have to Roca Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Roca Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Roca Therapeutics develops first-in-class small molecule therapies for patients with neovascular retinal diseases. Founded in 2021 as a spin-off from Nice University and SATT Sud Est, the company is a biotech focused on ophthalmology drug development based in Nice, France.
Investors · 3
Also in the syndicate · 2
3B Future Health Fund IIleadSATT Sud-Estlead
Funding
SEC filings, press & company announcements- Undisclosed amountseed funding roundSep 2022
3B Future Health Fund II (lead), SATT Sud-Est (lead)
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Roca Therapeutics do?
- Roca Therapeutics develops first-in-class small molecule therapies for patients with neovascular retinal diseases. Founded in 2021 as a spin-off from Nice University and SATT Sud Est, the company is a biotech focused on ophthalmology drug development based in Nice, France.
- Who are Roca Therapeutics's investors?
- Roca Therapeutics's investors include 3B Future Health Fund.
- Where is Roca Therapeutics headquartered?
- Roca Therapeutics is headquartered in Nice, FR.